Loading clinical trials...

Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2) | Clinical Trials | Clareo Health

COMPLETEDPhase 2NCT02558595

Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)

The purpose of this study is to observe the effects of niacinamide on markers of kidney injury, inflammation, kidney cyst growth and kidney function.

Lead sponsor: University of Kansas Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

NCT07161037 · Autosomal Dominant Polycystic Kidney Disease (ADPKD)

RECRUITINGPhase 3

Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)

NCT04939935 · Autosomal Dominant Polycystic Kidney Disease

RECRUITINGNA

Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease

NCT07454174 · Autosomal Dominant Polycystic Kidney Disease (ADPKD)

RECRUITINGPhase 2

A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

NCT06902558 · Autosomal Dominant Polycystic Kidney Disease

RECRUITING

Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease

NCT07260071 · Autosomal Dominant Polycystic Kidney Disease (ADPKD

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 11, 2019Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment36

Start dateSep 2015

Last updatedFeb 11, 2019

Condition

Polycystic Kidney Disease

Locations shown

University of Kansas Medical Center

Kansas City, Kansas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 11, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions